| scholarly article | Q13442814 |
| P50 | author | Aghdas Dehghani | Q86511349 |
| Maryam Malek | Q60988211 | ||
| P2093 | author name string | Marzieh Ghasemi | |
| Zahra Pezeshki | |||
| Mehdi Nematbakhsh | |||
| Farzaneh Ashrafi | |||
| Maryam Moeini | |||
| Azam Mansouri | |||
| Tahereh Safari | |||
| Mitra Navidi | |||
| Sima Jilanchi | |||
| Zohreh Zamani | |||
| Maryam Maleki | |||
| Fatemeh Eshraghi Jazi | |||
| Fariba Azarkish | |||
| Shadan Saberi | |||
| Alireza Rezaei | |||
| Fatemeh Moslemi | |||
| Soheyla Shirdavani | |||
| Bahar Mazaheri | |||
| Farzaneh Zeinali | |||
| P2860 | cites work | The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences | Q84557822 |
| Screening of herbal medicines for the recovery of cisplatin-induced nephrotoxicity | Q84588139 | ||
| Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats | Q84959808 | ||
| A combination of vitamin C and losartan for cisplatin-induced nephrotoxicity in rats | Q84971288 | ||
| Cisplatin induced toxicity in rat tissues: the protective effect of Lisosan G | Q85246455 | ||
| Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study | Q87245035 | ||
| Interactions of cis-platinum with cellular zinc and copper in rat liver and kidney tissues | Q93607332 | ||
| A study of the protective effect of chloride salts on cisplatin nephrotoxicity | Q93608572 | ||
| [Suppression of CDDP-induced renal toxicity by sodium selenite] | Q93635751 | ||
| Magnesium homeostasis following chemotherapy with cisplatin: a prospective study | Q93642366 | ||
| [Magnesium premedication prevents Cisplatin-induced nephrotoxicity in patients with esophageal and hypopharyngeal cancer] | Q95383442 | ||
| Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats | Q95720949 | ||
| Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats | Q95721006 | ||
| Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats | Q24807077 | ||
| Cisplatin nephrotoxicity and protection by milk thistle extract in rats | Q24816659 | ||
| Alpha-lipoic acid as a biological antioxidant | Q27863439 | ||
| The importance of selenium to human health | Q28036749 | ||
| INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE | Q28202030 | ||
| Free radicals, antioxidants, and nutrition | Q28205310 | ||
| Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats | Q28360981 | ||
| Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity | Q28574063 | ||
| Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats | Q28575870 | ||
| The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and nitric oxide in cisplatin-induced nephrotoxicity | Q28577841 | ||
| Cellular processing of platinum anticancer drugs | Q29617899 | ||
| Role of free radicals and catalytic metal ions in human disease: an overview | Q29618022 | ||
| The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo | Q33620539 | ||
| Sex-Related Difference in Nitric Oxide Metabolites Levels after Nephroprotectant Supplementation Administration against Cisplatin-Induced Nephrotoxicity in Wistar Rat Model: The Role of Vitamin E, Erythropoietin, or N-Acetylcysteine | Q33710782 | ||
| Vitamin e is a nephroprotectant agent in male but not in female in a model of Cisplatin-induced nephrotoxicity | Q33710810 | ||
| Magnesium: physiology and pharmacology | Q33807953 | ||
| Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney | Q33858698 | ||
| Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection. | Q33895592 | ||
| Vitamin E and its function in membranes | Q33900377 | ||
| Erythropoietin: physiology and pharmacology update | Q33963707 | ||
| Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia | Q34037781 | ||
| Unusual DNA binding modes for metal anticancer complexes | Q34071185 | ||
| Vitamin E and genome stability | Q34213956 | ||
| Nitric oxide as a bioregulator of apoptosis | Q34219296 | ||
| The Inhibition of Growth or Cell Division in Escherichia coli by Different Ionic Species of Platinum(IV) Complexes | Q34231767 | ||
| Role of the kidney in erythropoiesis | Q34241097 | ||
| Glutathione metabolism and its implications for health | Q34301684 | ||
| The pharmacology of the antioxidant lipoic acid | Q34447239 | ||
| Magnesium depletion enhances cisplatin-induced nephrotoxicity | Q34558414 | ||
| Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate | Q34609884 | ||
| Aqueous-ethanolic extract of morel mushroom mycelium Morchella esculenta, protects cisplatin and gentamicin induced nephrotoxicity in mice | Q34656909 | ||
| Particular aspects of platinum compounds used at present in cancer treatment | Q34671647 | ||
| Renal accumulation and urinary excretion of cisplatin in diabetic rats | Q41145925 | ||
| Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. | Q41400291 | ||
| Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment | Q41614645 | ||
| Hydrogen peroxide cytotoxicity in LLC-PK1 cells: A role for iron | Q41659475 | ||
| Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats | Q41702663 | ||
| The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect | Q41879041 | ||
| The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study | Q41881501 | ||
| Protective effects of the Morus alba L. leaf extracts on cisplatin-induced nephrotoxicity in rat. | Q41949526 | ||
| Effect of oral administration of magnesium on Cisplatin-induced nephrotoxicity in normal and streptozocin-induced diabetic rats | Q41963015 | ||
| Effects of anethole on seminal vesicle of albino rats | Q42056676 | ||
| Effect of pomegranate flower extract on cisplatin-induced nephrotoxicity in rats | Q42142820 | ||
| Effects of pretreatment with single-dose or intermittent oxygen on Cisplatin-induced nephrotoxicity in rats | Q42159451 | ||
| Effects of cisplatin and bleomycin on mature rat Leydig cell testosterone production | Q42489089 | ||
| Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects | Q42575787 | ||
| Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney | Q42725836 | ||
| Abrogation of cisplatin-induced nephrotoxicity in mice by alpha lipoic acid through ameliorating oxidative stress and enhancing gene expression of antioxidant enzymes | Q42730565 | ||
| Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys | Q42796944 | ||
| Effect of aqueous extract of Rheum ribes on cisplatin-induced nephrotoxicity in rat. | Q42881853 | ||
| Protective role of zinc picolinate on cisplatin-induced nephrotoxicity in rats | Q42917491 | ||
| Oral magnesium supplementation improves vascular function in elderly diabetic patients | Q42927176 | ||
| Amelioration of cisplatin induced nephrotoxicity by PTY: a herbal preparation. | Q43051102 | ||
| Lipoic acid effects on renal function, aminopeptidase activities and oxidative stress in Crotalus durissus terrificus envenomation in mice | Q43096120 | ||
| Cisplatin increases urinary sodium excretion in rats: gender-related differences | Q43127130 | ||
| Pretreatment with oxygen protects rat kidney from cisplatin nephrotoxicity | Q43144141 | ||
| Phenolic extract of soybean (Glycine max) attenuates cisplatin-induced nephrotoxicity in rats | Q43181762 | ||
| Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury | Q43231695 | ||
| A comparison of the rates of cisplatin (cDDP)--induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure | Q43275696 | ||
| N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity. | Q43291996 | ||
| Renal metallothionein and platinum levels in diabetic and nondiabetic rats injected with cisplatin | Q43458796 | ||
| Dietary phytoestrogens: a possible role in renal disease protection | Q43590475 | ||
| Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. | Q43592389 | ||
| Effects of losartan, prazosin and a vasopressin V1-receptor antagonist on renal and femoral blood flow in conscious sheep | Q43605698 | ||
| Radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2G. | Q43624421 | ||
| Losartan increases renal blood flow during isoflurane anesthesia in sheep | Q43782237 | ||
| Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats | Q43856694 | ||
| Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer | Q43910348 | ||
| Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action | Q43988771 | ||
| Redox reactions of tocopherol monoglucoside in aqueous solutions: a pulse radiolysis study | Q44022008 | ||
| Oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats. | Q44026752 | ||
| Functional impairment of renal organic cation transport in experimental diabetes | Q44036373 | ||
| Experimental study on effects of deferoxamine mesilate in ameliorating cisplatin-induced nephrotoxicity | Q44045287 | ||
| Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats | Q44054698 | ||
| Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. | Q44083098 | ||
| N-acetylcysteine as salvage therapy in cisplatin nephrotoxicity | Q44126017 | ||
| Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats | Q44362557 | ||
| A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo | Q44370277 | ||
| Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes | Q44380519 | ||
| Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine | Q44388993 | ||
| The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. | Q44437537 | ||
| Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin | Q44497745 | ||
| Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats | Q44530093 | ||
| Quantification of sodium thiosulphate protection on cisplatin-induced toxicities | Q44551209 | ||
| Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro | Q44552882 | ||
| Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells | Q44610333 | ||
| Erythropoietin protects against ischaemic acute renal injury | Q44737326 | ||
| Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. | Q34758366 | ||
| Effect of testosterone on Cisplatin-induced nephrotoxicity in surgically castrated rats | Q35052207 | ||
| 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo | Q35063808 | ||
| Inevitable glutathione, then and now. | Q35066756 | ||
| Oxidative stress, cell cycle, and neurodegeneration | Q35086148 | ||
| On the antioxidant effects of ascorbic acid and glutathione | Q35537606 | ||
| N-acetylcysteine in the prevention of radiocontrast-induced nephropathy | Q35640707 | ||
| Erythropoietin and the hypoxic brain | Q35858017 | ||
| Effect of foeniculum vulgare seed extract on mammary glands and oviducts of ovariectomised rats. | Q35902139 | ||
| Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial | Q36027863 | ||
| Erythropoietin: a novel neuroprotective cytokine. | Q36145943 | ||
| The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model | Q36196529 | ||
| Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model | Q36296439 | ||
| Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent | Q36349617 | ||
| Molecular biomarkers of oxidative stress in aquatic organisms in relation to toxic environmental pollutants. | Q36365839 | ||
| Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats | Q36415213 | ||
| Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer | Q36424378 | ||
| cis-Dichlorodiammineplatinum(II): cytological changes induced in Escherichia coli | Q36785141 | ||
| Direct cellular responses to platinum-induced DNA damage | Q36800400 | ||
| Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin | Q36861592 | ||
| Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts. | Q36883608 | ||
| Antioxidative effects of erythropoietin | Q36974225 | ||
| Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model. | Q36984545 | ||
| Cisplatin nephrotoxicity: mechanisms and renoprotective strategies | Q37084089 | ||
| Novel metals and metal complexes as platforms for cancer therapy | Q37137649 | ||
| Effect of population and gender on chemotherapeutic agent-induced cytotoxicity | Q37159518 | ||
| Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death | Q37192723 | ||
| Effects of Fennel Essential Oil on Cisplatin-induced Nephrotoxicity in Ovariectomized Rats. | Q37198928 | ||
| Inhibition of Nitric Oxide Synthase by L-NAME Promotes Cisplatin-Induced Nephrotoxicity in Male Rats | Q37217910 | ||
| Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female | Q37316465 | ||
| Cisplatin cytotoxicity: DNA and plasma membrane targets. | Q37320242 | ||
| Protective Effect of Standardized Extract of Ginkgo biloba against Cisplatin-Induced Nephrotoxicity | Q37382533 | ||
| Metal complexes, their cellular targets and potential for cancer therapy | Q37411425 | ||
| Modulation of gentamicin-induced renal dysfunction and injury by the phenolic extract of soybean (Glycine max). | Q50629771 | ||
| Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks | Q50894818 | ||
| Protective effect of CV247 against cisplatin nephrotoxicity in rats. | Q51011644 | ||
| Hypocalcemia Due to Hypomagnesemia and Reversible Parathyroid Hormone Unresponsiveness | Q52746747 | ||
| Effect of arginine on cisplatin-induced acute renal failure in the rat. | Q52871590 | ||
| Erythropoietin protects against cisplatin-induced nephrotoxicity by attenuating endoplasmic reticulum stress-induced apoptosis. | Q53161921 | ||
| The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era. | Q53189795 | ||
| Magnesium depletion in patients receiving cisplatin-based chemotherapy. | Q53584910 | ||
| Ring-Opened Adducts of the Anticancer Drug Carboplatin with Sulfur Amino Acids. | Q53991600 | ||
| Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity | Q54106611 | ||
| High-dose cisplatin with sodium thiosulfate protection. | Q54121260 | ||
| Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. | Q54443078 | ||
| Structure, Recognition, and Processing of Cisplatin-DNA Adducts. | Q55035583 | ||
| Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress | Q56608865 | ||
| Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury | Q58376211 | ||
| Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients | Q60221631 | ||
| Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin | Q64390050 | ||
| Long-term effects of acetazolamide and sodium chloride loading on cisplatin nephrotoxicity in the rat | Q67295874 | ||
| Efficacy of "two-route chemotherapy" using intra-arterial cisplatin and iv sodium thiosulfate, its antidote, in rat bladder tumor | Q67302269 | ||
| Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice | Q67552719 | ||
| Short term effects of cis-platinum on male reproduction, fertility and pregnancy outcome | Q67724495 | ||
| The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney | Q67956222 | ||
| [The influence of sodium thiosulfate on the antitumor effect of cisplatin in human gastric cancer cell lines] | Q67976420 | ||
| Sodium thiosulfate prevents cisplatin-induced hypomagnesemia | Q68051992 | ||
| Renal salt wasting in patients treated with cisplatin | Q68254464 | ||
| Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation | Q68269036 | ||
| [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice] | Q68470970 | ||
| Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats | Q69609476 | ||
| The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin | Q69637871 | ||
| Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice | Q69754923 | ||
| Intracellular free amino acid concentration in human muscle tissue | Q69767215 | ||
| Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure | Q69836533 | ||
| The mechanism of interaction between cisplatin and selenite | Q70140859 | ||
| Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors | Q70151567 | ||
| Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin | Q70408872 | ||
| Role of iron in postischemic renal injury in the rat | Q70413528 | ||
| Cisplatin-induced hypocalcemia and hypomagnesemia | Q70655053 | ||
| Renal excretion of magnesium and trace elements during cisplatin treatment | Q70678341 | ||
| Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma | Q70792112 | ||
| Effect of selenite on renal toxicity and antitumor activity of cis-diamminedichloroplatinum in mice inoculated with Ehrlich ascites tumor cell | Q70794870 | ||
| Reduction of cis-platinum induced nephrotoxicity by zinc histidine complex : the possible implication of nitric oxide | Q70803094 | ||
| Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells | Q70980301 | ||
| cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells | Q71230607 | ||
| Selenium efficiently depressed toxic side effect of cis-diamminedichloroplatinum | Q71239195 | ||
| Effects of low medium magnesium concentration on bone resorption in response to parathyroid hormone and 1,25-dihydroxyvitamin D in organ culture | Q71247435 | ||
| [New anthraquinones in Rubia cordifolia roots.] | Q80080336 | ||
| Therapeutic efficacy of DL-alpha-lipoic acid on cyclosporine A induced renal alterations | Q80586459 | ||
| Ascorbic acid monoglucoside as antioxidant and radioprotector | Q80860693 | ||
| Cisplatin-induced nephrotoxicity causes altered renal hemodynamics in Wistar Kyoto and spontaneously hypertensive rats: role of augmented renal alpha-adrenergic responsiveness | Q80977915 | ||
| Magnesium and potassium homeostasis during cisplatin treatment | Q81198087 | ||
| Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity | Q82977119 | ||
| Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity | Q83188800 | ||
| Effect of alcoholic extract of Nigella sativa on cisplatin-induced toxicity in rat | Q83568045 | ||
| Cisplatin-induced acute renal failure in mice is mediated by chymase-activated angiotensin-aldosterone system and interleukin-18 | Q84031124 | ||
| Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. | Q44748535 | ||
| Effect of sodium thiosulfate on the antitumor effect and nephrotoxicity of CDDP in human gastric cancer transplanted in nude mice | Q44793043 | ||
| Studies on the mechanism of protective effect of selenium on nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice | Q44851345 | ||
| Deferoxamine antioxidant activity on cerebellar granule cells gamma-irradiated in vitro | Q44869071 | ||
| The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats | Q44957994 | ||
| The successful regression of large solid sarcoma 180 tumors by platinum compounds | Q45004110 | ||
| Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin | Q45067435 | ||
| Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. | Q45221700 | ||
| Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats | Q45294160 | ||
| Scavenging action of zinc and green tea polyphenol on cisplatin and nickel induced nitric oxide generation and lipid peroxidation in rats | Q45297886 | ||
| Normobaric hyperoxia preconditioning ameliorates cisplatin nephrotoxicity | Q45361783 | ||
| The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats | Q45845862 | ||
| Anti-amnestic properties of Ginkgo biloba extract on impaired memory function induced by aluminum in rats | Q45893003 | ||
| Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats. | Q45921078 | ||
| Protection against cisplatin-induced nephrotoxicity in mice by Curcuma comosa Roxb. ethanol extract. | Q45964337 | ||
| Preventive role of exogenous testosterone on cisplatin-induced gonadal toxicity: an experimental placebo-controlled prospective trial | Q46053199 | ||
| Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: the protective effect of grape seed proanthocyanidin extract | Q46058349 | ||
| Erythropoietin reduces cumulative nephrotoxicity from cisplatin and enhances renal tubular cell proliferation | Q46101618 | ||
| Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice | Q46159319 | ||
| Cisplatin-induced nephrotoxicity in mice: protective role of Leea asiatica leaves | Q46304561 | ||
| Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract | Q46314784 | ||
| Naringenin attenuates cisplatin nephrotoxicity in rats | Q46434963 | ||
| Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage | Q46437628 | ||
| Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol | Q46470958 | ||
| Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet | Q46500697 | ||
| Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide | Q46522812 | ||
| Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats | Q46537280 | ||
| Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels | Q46542133 | ||
| Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma | Q46558429 | ||
| Protective effects of crocin against cisplatin-induced acute renal failure and oxidative stress in rats. | Q46573099 | ||
| Effects of administration of oral magnesium on plasma glucose and pathological changes in the aorta and pancreas of diabetic rats. | Q46667324 | ||
| Amelioration of cisplatin induced nephrotoxicity in mice by an ethyl acetate extract of Lagerstroemia speciosa (L). | Q46671217 | ||
| Selenium and lycopene attenuate cisplatin-induced testicular toxicity associated with oxidative stress in Wistar rats | Q46688121 | ||
| Cisplatin-induced cytotoxicity in BSO-exposed renal proximal tubular epithelial cells: sex, age, and species | Q46694747 | ||
| Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure | Q46715106 | ||
| Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. | Q46768393 | ||
| Histological, ultrastructural and immunohistochemical studies on the protective effect of ginger extract against cisplatin-induced nephrotoxicity in male rats. | Q46796633 | ||
| Back-regulation of six oxidative stress proteins with grape seed proanthocyanidin extracts in rat diabetic nephropathy | Q46818327 | ||
| Selective iNOS inhibition reduces renal damage induced by cisplatin. | Q46863211 | ||
| N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms | Q46953716 | ||
| The role of oxygen free radicals in cisplatin-induced acute renal failure in rats | Q47973729 | ||
| Cisplatin binding sites on human albumin | Q48010914 | ||
| Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas | Q48395620 | ||
| Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus | Q48430395 | ||
| Effects of cisplatin on testicular functions in rats. | Q48894445 | ||
| alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats | Q71341165 | ||
| Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats | Q71358014 | ||
| Effect of route of administration and dose on diabetes-induced protection against cisplatin nephrotoxicity | Q71381423 | ||
| The interaction of the anti-cancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration | Q71421127 | ||
| The role of the renin-angiotensin system in cisplatin nephrotoxicity | Q71438630 | ||
| Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, deferoxamine and torbafylline | Q71524609 | ||
| Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure | Q71568673 | ||
| Diethyldithiocarbamate protection against cisplatin nephrotoxicity: antioxidant system | Q71582398 | ||
| Intraperitoneal cisplatin with systemic thiosulfate protection | Q71842628 | ||
| Effects of cisplatin on testicular tissue and the Leydig cell-pituitary axis | Q71934584 | ||
| Acetohexamide reductase activities in liver microsomes and cytosol of cisplatin-treated male rats: cisplatin indirectly modulates the microsomal enzyme activity | Q71953550 | ||
| Selective inhibition of the inducible nitric oxide synthase by aminoguanidine | Q72077025 | ||
| Glucocorticoids regulate the transcription of Na(+)-K(+)-ATPase genes in the infant rat kidney | Q72158527 | ||
| Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds | Q72212220 | ||
| Effect of testosterone on cisplatin-induced testicular damage | Q72280599 | ||
| Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester | Q72336793 | ||
| Effects of oral magnesium supplementation on acute experimental cyclosporin nephrotoxicity | Q72407547 | ||
| Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines | Q72789932 | ||
| Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats | Q72817130 | ||
| Functional modulation of the mineralocorticoid receptor by cis-diamminedichloroplatinum (II) | Q73024310 | ||
| Effects of dietary sodium and magnesium on cyclosporin A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats | Q73115406 | ||
| Testosterone propionate prevents cisplatin induced inhibition of renal beta-glucuronidase activity in rats | Q73137758 | ||
| Gender differences in expression of organic cation transporter OCT2 in rat kidney | Q73196386 | ||
| Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity | Q73293245 | ||
| The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate | Q73433534 | ||
| The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients | Q73446757 | ||
| Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study | Q73514442 | ||
| Cisplatin complexes with phosphatidylserine in membranes | Q73611930 | ||
| Hormonal regulation of organic cation transporter OCT2 expression in rat kidney | Q73794772 | ||
| Diabetes-induced protection from cisplatin nephrotoxicity is associated with impairment of energy-dependent uptake by renal cortex slices | Q73837099 | ||
| Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats | Q73862978 | ||
| Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system | Q73914146 | ||
| In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity | Q74165125 | ||
| Reduction of cisplatin toxicity and lethality by sodium malate in mice | Q74226356 | ||
| Mechanism of the protective effect of sodium malate on cisplatin-induced toxicity in mice | Q74352136 | ||
| Effects of zinc gluconate on nephrotoxicity and glutathione metabolism disorder induced by cis-platin in mice | Q77130416 | ||
| Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18 | Q77399412 | ||
| Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity | Q77650651 | ||
| Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones | Q77664958 | ||
| Triterpene antioxidants from ganoderma lucidum | Q78234223 | ||
| Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism | Q78329953 | ||
| Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats | Q79401246 | ||
| Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats | Q79860078 | ||
| Effect of selenium on Cisplatin-induced nephrotoxicity in rats | Q79894162 | ||
| Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study | Q80061938 | ||
| Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models | Q37418479 | ||
| Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study | Q37455009 | ||
| Protective effect of selenium on cisplatin induced nephrotoxicity: A double-blind controlled randomized clinical trial | Q37476160 | ||
| Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice | Q37479069 | ||
| Grape seed proanthocyanidin extract protects from cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis | Q37588562 | ||
| Cisplatin nephrotoxicity: experimental and clinical studies | Q37905485 | ||
| The physiological role of zinc as an antioxidant | Q37923918 | ||
| A single d(GpG) cisplatin adduct on the estrogen response element decreases the binding of the estrogen receptor. | Q38316074 | ||
| Biological and toxic properties of deferoxamine | Q38691934 | ||
| Cisplatin nephrotoxicity. A review | Q38730217 | ||
| Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation. | Q38983107 | ||
| Cisplatin toxicity reduced in human cultured renal tubular cells by oxygen pretreatment. | Q39100793 | ||
| Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1/2 as well as AKT signaling | Q39106280 | ||
| Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs | Q39111177 | ||
| Progesterone and estrogen prevent cisplatin-induced apoptosis of lung cancer cells | Q39182110 | ||
| Cisplatin inhibits testosterone synthesis by a mechanism that includes the action of reactive oxygen species (ROS) at the level of P450scc. | Q39287169 | ||
| Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. | Q39373122 | ||
| The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis | Q39485185 | ||
| Influence of tamoxifen on cisplatin-sensitivity and estrogen receptors expression in ovarian carcinoma cell lines | Q39702090 | ||
| Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro. | Q39832116 | ||
| Cisplatin: synthesis, antitumour activity and mechanism of action | Q39835716 | ||
| Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice. | Q39895977 | ||
| Sex-related differences in cisplatin-induced neuropathy in rats. | Q39926091 | ||
| Impaired Release of Parathyroid Hormone in Magnesium Deficiency | Q39985111 | ||
| Attenuating the toxicity of cisplatin by using selenosulfate with reduced risk of selenium toxicity as compared with selenite | Q40064696 | ||
| Regulation of biosynthesis of nitric oxide. | Q40389134 | ||
| New cisplatin analogues in development. A review | Q40491603 | ||
| The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway | Q40501567 | ||
| Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. | Q40530140 | ||
| Prospects for the use of antioxidant therapies | Q40541276 | ||
| Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair | Q40804560 | ||
| Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin | Q40848346 | ||
| Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients | Q41103421 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 295-314 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Asian Pacific Journal of Cancer Prevention | Q15759519 |
| P1476 | title | Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences | |
| P478 | volume | 18 |
| Q47711895 | Age and Gender Related Renal Side Effects of Cisplatin in Animal Model |
| Q55012927 | Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database. |
| Q58087069 | Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells |
| Q64985983 | Liver-targeted delivery of liposome-encapsulated curcumol using galactosylated-stearate. |
| Q64264778 | Losartan risk for female in cisplatin-induced nephrotoxicity |
| Q53184265 | New Insight of OCT2 Regulation as Mediator for Cisplatin- Induced Nephrotoxicity |
| Q57165530 | Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury |
| Q94594727 | Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity |
| Q57071692 | S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism |
| Q92003983 | Squalene attenuates the oxidative stress and activates AKT/mTOR pathway against cisplatin-induced kidney damage in mice |
| Q58730261 | Whortleberry protects kidney against the cisplatin-induced nephrotoxicity: an experimental study |
Search more.